Digital health technologies to help manage symptoms of psychosis and prevent relapse in adults and young people: early value assessment (HTE17)Product type:GuidanceProgramme:Health technology evaluationPublished: 25 March 2024
Virtual reality technologies for treating agoraphobia or agoraphobic avoidance: early value assessment (HTE15)Product type:GuidanceProgramme:Health technology evaluationPublished: 15 November 2023
KardiaMobile 6L for measuring cardiac QT interval in adults having antipsychotic medication (HTE10)Product type:GuidanceProgramme:Health technology evaluationPublished: 26 September 2023